Research institute
Rudy Tanzi, Chair of the Cure Alzheimer’s Fund Research Leadership Group and the Kennedy Professor of Neurology at Harvard University and at Massachusetts General Hospital, and Rob Fried, CEO of ChromaDex, took time to speak with BioSpace about the current understanding of Alzheimer’s and some interesting approaches to drug development.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Scientists from A*STAR’s Bioinformatics Institute (BII), together with collaborators in Amsterdam, have discovered that the evolution of influenza viruses from natural selection is more closely linked to the transmission stage rather than within the human body.
So far, a vaccine for HIV has been elusive. However, researchers with Scripps Research Institute recently published positive data about its HIV vaccine in the journal Immunity that suggests one might be on the horizon.
The Lead Discovery Center GmbH (LDC) and the University of Duisburg-Essen (UDE) have received EUR 905,000 in funding from the state of North Rhine-Westphalia as part of its lead market competition, LifeSciences.NRW.
In writing literally hundreds of stories this year, two BioSpace writers, Alex Keown and Mark Terry, found certain stories particularly intriguing or impactful. Some of those were such big topics that they were covered over a series of stories. Looking back at 2018, here are their Top 10.
Knowing how mutations in cancer cells work will help researchers better understand how they evolve to become resistant to drugs
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Microsoft co-founder Paul Allen set aside $125 million to fund a new division at a scientific institute he founded to focus on understanding the immune system. This morning, it was reported that the Allen Institute is expanding.
Potential upside of more than 42% compared to MAB closing price of EUR 1.66 on 10 December 2018
PRESS RELEASES